Global Clinical Engagement Lead — Investigator Relations

Beeline Medicines; México; Presencial; MXN 900.000 - 1.300.000; Jornada completa

Descripción de la vacante

Beeline Medicines is seeking a Clinical Engagement Lead to work field-based within Mexico and LATAM. The role focuses on building and managing investigator and site relationships across the globe to support the organization’s clinical trial portfolio.

This position serves as the primary site-facing liaison with investigators and academic centers, guiding site identification, feasibility, protocol discussions, initiation, and ongoing engagement throughout the trial lifecycle.

Responsabilidades

• Build and manage region/country investigator and clinical site relationships with principal investigators, academic medical centers, and research sites.
• Lead site identification and feasibility activities for clinical trials, assess investigator interest and patient access, and advise on site selection and activation.
• Serve as the primary clinical liaison to investigators, facilitating protocol discussions and site initiation and training throughout the trial lifecycle.
• Support clinical trial enrollment and retention by identifying challenges and implementing site-level solutions to maintain engagement.
• Capture and communicate regional clinical landscape intelligence to Clinical Development, Medical Affairs, and Commercial teams.
• Partner with Medical Affairs MSLs to coordinate scientific engagement activities at the investigator level and delineate clinical vs medical affairs boundaries.
• Represent Beeline Medicines at clinical and scientific meetings, investigator symposia, conferences, and site visits.

Descripción del empleo

Beeline Medicines is seeking a Clinical Engagement Lead to work field-based within Mexico and LATAM. The role focuses on building and managing investigator and site relationships across the globe to support the organization’s clinical trial portfolio.

This position serves as the primary site-facing liaison with investigators and academic centers, guiding site identification, feasibility, protocol discussions, initiation, and ongoing engagement throughout the trial lifecycle.